Blog 13 March 2026 Phase 4 and real-world evidence: not a spectrum, a strategic choice Phase 4 clinical trials and real-world evidence (RWE) studies serve fundamentally different purposes in post-approval drug development. Phase... Learn more
News 12 March 2026 Castor Joins C-Path eCOA Consortium, Surpassing 300 Industry Study Milestone Castor joins the Critical Path Institute (C-Path) eCOA Consortium, bringing insights from 300+ industry studies to advance participant-centric... Learn more
White papers & guides 27 February 2026 Castor’s Global e-Consent Matrix Electronic consent is now approved or conditionally approved in 27 of 33 countries assessed in Castor's eConsent Country... Learn more
